CR11432A - Acidos carboxilicos bifenil y derivados de los mismos - Google Patents
Acidos carboxilicos bifenil y derivados de los mismosInfo
- Publication number
- CR11432A CR11432A CR11432A CR11432A CR11432A CR 11432 A CR11432 A CR 11432A CR 11432 A CR11432 A CR 11432A CR 11432 A CR11432 A CR 11432A CR 11432 A CR11432 A CR 11432A
- Authority
- CR
- Costa Rica
- Prior art keywords
- bifenil
- derivatives
- same
- carboxilic acids
- carboxilic
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 150000007513 acids Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
La presente invencion se refiere a compuestos que tienen la formula general (I) con las definiciones R1, R2, R3, Y R4 dadas a continuacion y/o una sal o ester de estos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US98058707P | 2007-10-17 | 2007-10-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR11432A true CR11432A (es) | 2010-10-14 |
Family
ID=40345060
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR11432A CR11432A (es) | 2007-10-17 | 2010-05-17 | Acidos carboxilicos bifenil y derivados de los mismos |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7897643B2 (es) |
| EP (1) | EP2215044B8 (es) |
| JP (1) | JP5404634B2 (es) |
| KR (1) | KR101579744B1 (es) |
| CN (1) | CN101861297B (es) |
| AU (1) | AU2008312771B2 (es) |
| BR (1) | BRPI0817424A2 (es) |
| CA (1) | CA2702832A1 (es) |
| CO (1) | CO6270313A2 (es) |
| CR (1) | CR11432A (es) |
| DK (1) | DK2215044T3 (es) |
| EA (1) | EA017616B1 (es) |
| ES (1) | ES2395083T3 (es) |
| IL (1) | IL205047A (es) |
| MX (1) | MX2010004261A (es) |
| NI (1) | NI201000058A (es) |
| WO (1) | WO2009051948A1 (es) |
| ZA (1) | ZA201003432B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0818773A2 (pt) * | 2007-10-19 | 2015-04-14 | Janssen Pharmaceutica Nv | Moduladores de gama-secretase ligados a carbono |
| AU2008312612B2 (en) * | 2007-10-19 | 2013-11-28 | Janssen Pharmaceutica, N.V. | Piperidinyl and piperazinyl modulators of gamma-secretase |
| KR20100082351A (ko) * | 2007-10-19 | 2010-07-16 | 얀센 파마슈티카 엔.브이. | γ-세크레타아제의 아민 결합된 조절제 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5877399A (en) | 1994-01-27 | 1999-03-02 | Johns Hopkins University | Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease |
| WO2001078721A1 (en) | 2000-04-13 | 2001-10-25 | Mayo Foundation For Medical Education And Research | Aβ42 LOWERING AGENTS |
| DE10131899A1 (de) | 2001-07-04 | 2003-02-27 | Boehringer Ingelheim Pharma | In vitro-Screening-Assay für gamma-Secretase |
| WO2006004555A1 (en) | 2004-06-30 | 2006-01-12 | Paysetter Pte Ltd | System and method for facilitating transfer of physical money and/or credit |
| DE102004033876B4 (de) | 2004-07-13 | 2009-01-15 | Christoph Kaesbohrer | Dreidimensionales Struktursystem |
| EP1650183A1 (en) * | 2004-10-21 | 2006-04-26 | Cellzome Ag | (Benzyloxy-biphenyl) acetic acids and derivatives thereof and their use in therapy |
-
2008
- 2008-09-26 WO PCT/US2008/077779 patent/WO2009051948A1/en not_active Ceased
- 2008-09-26 AU AU2008312771A patent/AU2008312771B2/en not_active Ceased
- 2008-09-26 BR BRPI0817424-5A patent/BRPI0817424A2/pt not_active IP Right Cessation
- 2008-09-26 EP EP08839835A patent/EP2215044B8/en active Active
- 2008-09-26 EA EA201070478A patent/EA017616B1/ru not_active IP Right Cessation
- 2008-09-26 KR KR1020107010759A patent/KR101579744B1/ko not_active Expired - Fee Related
- 2008-09-26 US US12/238,549 patent/US7897643B2/en not_active Expired - Fee Related
- 2008-09-26 DK DK08839835.9T patent/DK2215044T3/da active
- 2008-09-26 MX MX2010004261A patent/MX2010004261A/es active IP Right Grant
- 2008-09-26 ES ES08839835T patent/ES2395083T3/es active Active
- 2008-09-26 CN CN200880116649.2A patent/CN101861297B/zh not_active Expired - Fee Related
- 2008-09-26 CA CA2702832A patent/CA2702832A1/en not_active Abandoned
- 2008-09-26 JP JP2010530013A patent/JP5404634B2/ja not_active Expired - Fee Related
-
2010
- 2010-04-13 IL IL205047A patent/IL205047A/en not_active IP Right Cessation
- 2010-04-15 NI NI201000058A patent/NI201000058A/es unknown
- 2010-05-10 CO CO10055388A patent/CO6270313A2/es not_active Application Discontinuation
- 2010-05-14 ZA ZA2010/03432A patent/ZA201003432B/en unknown
- 2010-05-17 CR CR11432A patent/CR11432A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR101579744B1 (ko) | 2015-12-23 |
| AU2008312771A1 (en) | 2009-04-23 |
| US20090105344A1 (en) | 2009-04-23 |
| JP2011500691A (ja) | 2011-01-06 |
| JP5404634B2 (ja) | 2014-02-05 |
| ES2395083T3 (es) | 2013-02-08 |
| EA201070478A1 (ru) | 2010-10-29 |
| BRPI0817424A2 (pt) | 2015-06-16 |
| IL205047A0 (en) | 2010-11-30 |
| KR20100090264A (ko) | 2010-08-13 |
| EP2215044A1 (en) | 2010-08-11 |
| CN101861297B (zh) | 2014-04-23 |
| ES2395083T8 (es) | 2014-11-17 |
| ZA201003432B (en) | 2012-07-25 |
| EP2215044B8 (en) | 2012-10-03 |
| AU2008312771B2 (en) | 2012-11-01 |
| EP2215044B1 (en) | 2012-08-29 |
| DK2215044T3 (da) | 2012-11-26 |
| MX2010004261A (es) | 2010-04-30 |
| CN101861297A (zh) | 2010-10-13 |
| EA017616B1 (ru) | 2013-01-30 |
| CO6270313A2 (es) | 2011-04-20 |
| WO2009051948A1 (en) | 2009-04-23 |
| CA2702832A1 (en) | 2009-04-23 |
| US7897643B2 (en) | 2011-03-01 |
| NI201000058A (es) | 2010-09-13 |
| IL205047A (en) | 2014-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1119784T1 (el) | Ακετυλιωμενες σαλικυλικες ενωσεις λιπαρου οξεος και οι χρησεις αυτων | |
| CY1110489T1 (el) | Παραγωγα ισοκινολινης | |
| CR10662A (es) | Compuestos de metilpiridopirimidinona | |
| CU20090017A7 (es) | Peptidomimeticos de smac utiles como inhibidores de proteinas de apoptosis (iap) | |
| CR11454A (es) | Derivados de isoxazolo-piridina | |
| GT200600134A (es) | Compuestos novedosos de derivados de aminosulfonilo | |
| CR20110684A (es) | Derivados de imidazolidin-2-ona 1,3-disustituida como inhibidores de cyp17 | |
| CR10027A (es) | Nuevos derivados de pirrol fusionado | |
| UY30941A1 (es) | Inhibidores de serina proteasas | |
| CR10420A (es) | Derivados biciclicos como inhibibidores de cetp | |
| CY1112102T1 (el) | Υποκατεστημενες πυριμιδοδιαζεπινες χρησιμες ως αναστολεις plk1 | |
| UY31562A1 (es) | Azolilmetiloxiranos, su uso y agentes que los contienen | |
| MX2010005005A (es) | Limpiador dental. | |
| CR11130A (es) | Acidos benzoilamino-indan-2-carboxilicos sustituidos y compuestos relacionados | |
| UY31560A1 (es) | Azolilmetiloxiranos, su uso y agentes que los contienen | |
| CR9331A (es) | Inhibidores de vegf-r2 y metodos | |
| EA201170456A1 (ru) | Синергические комбинации макроциклического ингибитора вируса гепатита с и нуклеозида | |
| UY31563A1 (es) | Azolilmetiloxiranos, su uso y agentes que los contienen | |
| CR20110219A (es) | Ácidos naftilacéticos | |
| CY1113102T1 (el) | Ενωσεις φαινυλπροπιοναμιδιου και η χρηση αυτων | |
| AR062211A1 (es) | Derivados de 6-carboxi-normorfinano. composiciones farmaceuticas | |
| PA8779101A1 (es) | "compuestos tricíclicos como inhibidores de metaloproteinasas matriciales" | |
| AR051577A1 (es) | Derivados eter sustituidos por hexafluorisopropanol | |
| CY1116168T1 (el) | Συγκρυσταλλοι και αλατα αναστολεων toy ccr3 | |
| CO6331463A2 (es) | Nuevos derivados de triazolo(4,3-a)piridina, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion particularmente como inhibidores de met |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal (granting procedure) |